Atea Pharmaceuticals Stock Buy Hold or Sell Recommendation

AVIR -  USA Stock  

USD 7.53  0.23  3.15%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Atea Pharmaceuticals is 'Strong Hold'. Macroaxis provides Atea Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AVIR positions. The advice algorithm takes into account all of Atea Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Atea Pharmaceuticals' buy-and-hold perspective. Please continue to Atea Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Atea Pharmaceuticals and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Atea Pharmaceuticals.

Execute Atea Pharmaceuticals Buy or Sell Advice

The Atea Pharmaceuticals recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Atea Pharmaceuticals. Macroaxis does not own or have any residual interests in Atea Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Atea Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Atea PharmaceuticalsBuy Atea Pharmaceuticals
Strong Hold

Volatility

Slightly riskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Below AverageDetails

Economic Sensitivity

Responds to the marketDetails

Analyst Consensus

HoldDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails
For the selected time horizon Atea Pharmaceuticals has a Risk Adjusted Performance of 0.1242, Jensen Alpha of 0.5307, Total Risk Alpha of 0.7188, Sortino Ratio of 0.1274 and Treynor Ratio of 0.2418
We provide trade advice to complement the prevailing expert consensus on Atea Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Atea Pharmaceuticals is not overpriced, please confirm all Atea Pharmaceuticals fundamentals, including its cash and equivalents, beta, and the relationship between the price to sales and book value per share . Given that Atea Pharmaceuticals has a number of shares shorted of 1.96 M, we suggest you to validate Atea Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Atea Pharmaceuticals Trading Alerts and Improvement Suggestions

Atea Pharmaceuticals appears to be risky and price may revert if volatility continues
Atea Pharmaceuticals currently holds about 705.55 M in cash with (129.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Atea Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Roughly 67.0% of the company shares are held by institutions such as insurance companies
Latest headline from simplywall.st: Atea Pharmaceuticals, Inc.s Shares Not Telling The Full Story - Simply Wall St

Atea Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Atea Pharmaceuticals analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Atea Pharmaceuticals analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price7.50
Target Median Price7.50
Target High Price9.00
Recommendation Mean2.60
Number Of Analyst Opinions2
Target Low Price6.00
Average Consensus Hold
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Atea Pharmaceuticals Returns Distribution Density

The distribution of Atea Pharmaceuticals' historical returns is an attempt to chart the future uncertainty of Atea Pharmaceuticals' future price movements. The chart of the probability distribution of Atea Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Atea Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Atea Pharmaceuticals returns is essential to provide solid investment advice for Atea Pharmaceuticals stock.
Mean Return0.37Value At Risk-5.08
Potential Upside7.44Standard Deviation4.31
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Atea Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Atea Pharmaceuticals Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Atea Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atea Pharmaceuticals backward and forwards among themselves. Atea Pharmaceuticals' institutional investor refers to the entity that pools money to purchase Atea Pharmaceuticals' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares12.6 M90.8 M
Vanguard Group IncCommon Shares6.7 M48.6 M
Blackrock IncCommon Shares6.6 M47.8 M
Ecor1 Capital LlcCommon Shares6.3 M45.8 M
Bain Capital Life Sciences Investors LlcCommon Shares2.5 M17.9 M
Federated Hermes IncCommon Shares2.1 M14.8 M
State Street CorpCommon Shares1.9 M13.5 M
Note, although Atea Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Atea Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Atea Pharmaceuticals or Pharmaceutical Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Atea Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Atea Pharmaceuticals stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.53
β
Beta against DOW1.50
σ
Overall volatility
4.37
Ir
Information ratio 0.11

Atea Pharmaceuticals Volatility Alert

Atea Pharmaceuticals shows above-average downside volatility for the selected time horizon. We advise investors to inspect Atea Pharmaceuticals further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Atea Pharmaceuticals future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Atea Pharmaceuticals' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Atea Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Atea Pharmaceuticals Implied Volatility

Atea Pharmaceuticals' implied volatility exposes the market's sentiment of Atea Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Atea Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Atea Pharmaceuticals stock will not fluctuate a lot when Atea Pharmaceuticals' options are near their expiration.

Atea Pharmaceuticals Fundamentals Vs Peers

Comparing Atea Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Atea Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Atea Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Atea Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Atea Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Atea Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Atea Pharmaceuticals to competition
FundamentalsAtea PharmaceuticalsPeer Average
Return On Equity7.64 %(0.31) %
Return On Asset5.26 %(0.14) %
Profit Margin16.96 %(1.27) %
Operating Margin22.97 %(5.51) %
Current Valuation(79.07 M)16.62 B
Shares Outstanding83.26 M571.82 M
Shares Owned by Insiders10.52 %10.09 %
Shares Owned by Institutions66.90 %39.21 %
Number of Shares Shorted1.96 M4.71 M
Price to Earning13.50 X28.72 X
Price to Book0.92 X9.51 X
Price to Sales2.19 X11.42 X
Revenue285.38 M9.43 B
Gross Profit184.16 M27.38 B
EBITDA65.58 M3.9 B
Net Income48.4 M570.98 M
Cash and Equivalents705.55 M2.7 B
Cash per Share8.47 X5.01 X
Total Debt2.88 M5.32 B
Debt to Equity0.004 %48.70 %
Current Ratio24.93 X2.16 X
Book Value Per Share8.17 X1.93 K
Cash Flow from Operations(129.18 M)971.22 M
Short Ratio3.80 X4.00 X
Earnings Per Share0.56 X3.12 X
Number of Employees6418.84 K
Beta0.37-0.15
Market Capitalization623.6 M19.03 B
Total Asset97.97 M29.47 B
Retained Earnings(269.19 M)9.33 B
Working Capital91.63 M1.48 B
Current Asset97.88 M9.34 B
Current Liabilities6.25 M7.9 B
   Acquisition by Hammond Janet Mj of 190000 shares of Atea Pharmaceuticals subject to Rule 16b-3 [view details]

Atea Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Atea Pharmaceuticals . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution31225.36
Daily Balance Of Power0.5476
Rate Of Daily Change1.03
Day Median Price7.36
Day Typical Price7.42
Market Facilitation Index0.0
Price Action Indicator0.29

About Atea Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Atea Pharmaceuticals? Buying financial instruments such as Atea Pharmaceuticals Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Atea Pharmaceuticals investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2015 2016 2021 2022 (projected)
Accounts Payable3.9 M1.4 M131.4 K134.86 K
Receivables700 K600 K895.5 K919.07 K

Use Investing Ideas to Build Portfolios

In addition to having Atea Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aircraft Thematic Idea Now

Aircraft
Aircraft Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Aircraft theme has 38 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aircraft Theme or any other thematic opportunities.
View All  Next Launch Aircraft
Please continue to Atea Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Is Atea Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea Pharmaceuticals. If investors know Atea Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.